ENGN logo

ENGN
enGene Holdings Inc

1,162
Mkt Cap
$482.32M
Volume
95,288.00
52W High
$12.25
52W Low
$2.65
PE Ratio
-3.19
ENGN Fundamentals
Price
$7.20
Prev Close
$7.27
Open
$7.31
50D MA
$8.46
Beta
0.49
Avg. Volume
568,745.53
EPS (Annual)
-$2.29
P/B
1.71
Rev/Employee
$0.00
$206.55
Loading...
Loading...

About

enGene Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in developing gene therapies. It is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs. The company was founded by Anthony T. Cheung on April 24, 2023 and is headquartered in Saint-Laurent, Canada.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
82

Frequently Asked Questions

What is Market Cap of enGene Therapeutics Inc.?
What is the 52-week high for enGene Therapeutics Inc.?
What is the 52-week low for enGene Therapeutics Inc.?
What is enGene Therapeutics Inc. stock price today?
What was enGene Therapeutics Inc. stock price yesterday?
What is the PE ratio of enGene Therapeutics Inc.?
What is the Price-to-Book ratio of enGene Therapeutics Inc.?
What is the 50-day moving average of enGene Therapeutics Inc.?
How many employees does enGene Therapeutics Inc. have?

Latest ENGN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.